2,911 Shares in Molina Healthcare, Inc $MOH Purchased by Jackson Thornton Wealth Management LLC

Jackson Thornton Wealth Management LLC acquired a new stake in shares of Molina Healthcare, Inc (NYSE:MOH) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 2,911 shares of the company’s stock, valued at approximately $425,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. AQR Capital Management LLC boosted its stake in Molina Healthcare by 217.0% in the 3rd quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after buying an additional 2,008,458 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its holdings in shares of Molina Healthcare by 10.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 2,171,433 shares of the company’s stock valued at $376,831,000 after acquiring an additional 201,772 shares during the period. Invesco Ltd. grew its holdings in shares of Molina Healthcare by 24.2% in the 4th quarter. Invesco Ltd. now owns 1,690,981 shares of the company’s stock worth $293,453,000 after purchasing an additional 329,679 shares during the last quarter. Victory Capital Management Inc. grew its holdings in shares of Molina Healthcare by 46.4% in the 4th quarter. Victory Capital Management Inc. now owns 1,410,604 shares of the company’s stock worth $244,796,000 after purchasing an additional 447,078 shares during the last quarter. Finally, 8 Knots Management LLC acquired a new stake in shares of Molina Healthcare during the 4th quarter worth about $198,942,000. Institutional investors own 98.50% of the company’s stock.

Insider Transactions at Molina Healthcare

In other news, CAO Maurice Hebert sold 600 shares of the firm’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the transaction, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of Molina Healthcare stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the sale, the insider owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This represents a 20.96% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 1.44% of the company’s stock.

Molina Healthcare Stock Up 2.8%

Shares of MOH opened at $234.11 on Wednesday. The business’s fifty day moving average price is $196.62 and its two-hundred day moving average price is $171.71. The firm has a market capitalization of $12.20 billion, a price-to-earnings ratio of 69.26 and a beta of 0.74. Molina Healthcare, Inc has a 52 week low of $121.06 and a 52 week high of $237.50. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to analyst estimates of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The firm’s revenue for the quarter was down 3.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, analysts predict that Molina Healthcare, Inc will post 5.23 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Cantor Fitzgerald boosted their price target on shares of Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Royal Bank Of Canada started coverage on Molina Healthcare in a report on Tuesday, June 23rd. They set a “sector perform” rating and a $216.00 price target for the company. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $129.00 price objective on shares of Molina Healthcare in a research report on Friday, April 24th. Truist Financial boosted their price objective on Molina Healthcare from $180.00 to $205.00 and gave the stock a “hold” rating in a research note on Monday, May 11th. Finally, Wells Fargo & Company increased their target price on Molina Healthcare from $141.00 to $159.00 and gave the stock an “equal weight” rating in a report on Monday, April 27th. Three investment analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, Molina Healthcare currently has an average rating of “Hold” and a consensus price target of $184.81.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.